| dc.contributor.author |
Björn Guðbjörnsson 1955 |
is |
| dc.contributor.author |
Sigurður B. Þorsteinsson 1943 |
is |
| dc.contributor.author |
Helgi Sigvaldason 1931 |
is |
| dc.contributor.author |
Rannveig Alma Einarsdóttir 1953 |
is |
| dc.contributor.author |
Magnús Jóhannsson 1942 |
is |
| dc.contributor.author |
Helga Zoëga 1976 |
is |
| dc.contributor.author |
Matthías Eggert Halldórsson 1948 |
is |
| dc.contributor.author |
Guðmundur Þorgeirsson 1946 |
is |
| dc.date.accessioned |
2018-12-04T08:55:47Z |
|
| dc.date.issued |
2010 |
|
| dc.identifier.uri |
http://hdl.handle.net/10802/16923 |
|
| dc.description |
Myndefni: Töflur. |
is |
| dc.language.iso |
en |
|
| dc.relation.ispartof |
European journal of clinical pharmacology. 2010; 66 (6): bls. 619-625 |
is |
| dc.relation.ispartof |
991002416989706886 |
|
| dc.relation.uri |
https://link.springer.com/content/pdf/10.1007/s00228-010-0789-2.pdf |
|
| dc.subject |
Lyfjafræði |
is |
| dc.subject |
Verkjalyf |
is |
| dc.subject |
Lyfjanotkun |
is |
| dc.subject |
Áhættuþættir |
is |
| dc.subject |
Hjartasjúkdómar |
is |
| dc.subject |
Æðasjúkdómar |
is |
| dc.subject |
Ungt fólk |
is |
| dc.subject |
Ísland |
is |
| dc.title |
Rofecoxib, but not celecoxib, increases the risk of thromboembolic cardiovascular events in young adults : a nationwide registry-based study |
en |
| dc.type |
Tímaritsgrein |
is |
| dc.description.embargo |
ævinlega ALL |
is |
| dc.date.embargo |
ævinlega |
|
| dc.identifier.gegnir |
991010916319706886 |
|
| dc.description.ix |
Islandia extranea |
is |
